Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 27, 2020Breast Cancer ResearchOpen Access

Effect of body mass index on response to neo-adjuvant therapy in HER2-positive breast cancer: an exploratory analysis of the NeoALTTO trial

View Full Paper
Ask AI
Bookmark
Share

Authors

SCSerena Di CosimoFondazione IRCCS Istituto Nazionale dei TumoriLPLuca PorcuUniversity of CambridgeDADominique Agbor‐TarhFrontier Agriculture (United Kingdom)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cosimo et al. (2020) studied this question.

synapsesocial.com/papers/6a6f7e7fa7fbea1e4407c22ehttps://doi.org/10.1186/s13058-020-01356-w
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Insulin/Insulin-Like Growth Factors in Cancer: New Roles for the Aryl Hydrocarbon Receptor, Tumor Resistance Mechanisms, and New Blocking Strategies2015 · 39 citations
  2. 2Obesity and Breast Cancer: Progress to Understanding the Relationship2009 · 131 citations
  3. 3Is Breast Cancer the Same Disease in Asian and Western Countries?2010 · 655 citations
  4. 4Relationship Between Obesity and Pathologic Response to Neoadjuvant Chemotherapy Among Women With Operable Breast Cancer2008 · 208 citations
  5. 5Type 2 Diabetes and Obesity Metabolic Interactions: Common Factors for Breast Cancer Risk and Novel Approaches to Prevention and Therapy2012 · 67 citations